Corrigendum to "Sophoricoside attenuates lipopolysaccharide-induced acute lung injury by activating the AMPK/Nrf2 signaling axis" [Int. Immunopharmacol. 90 (2021) 107187]

Int Immunopharmacol. 2023 Nov;124(Pt A):111008. doi: 10.1016/j.intimp.2023.111008. Epub 2023 Oct 6.
No abstract available

Publication types

  • Published Erratum